Over the past decade, the Human Cell Atlas community has accomplished something that will define a generation of biology.

Whole-transcriptome profiling across a large tissue capture area can generate 2x more unique genes per sample than probe-based technologies SAN DIEGO, June 8, 2026 /PRNewswire/ -- Illumina, Inc.

WALTHAM, Mass., June 08, 2026--(BUSINESS WIRE)--Vizgen, Inc., a leader in spatial multiomics and developer of the MERSCOPE Ultra™ Platform, today announced it will debut a 3D Volumetric Tissue Mapping ...

A detailed description of the pipeline, methods, and results can be found in the following article: Giraud-Sauveur, F., Blampey, Q., Benkirane, H. et al. STHELAR, a multi-tissue dataset linking ...

A brightly colored image composed of dots that are each one of many colors. At the center of the image is a yellow-and-pink fishhook shape with clusters of green dots and clusters of blue dots around ...

Abstract: Reconstructing three-dimensional (3D) structures from consecutive tissue slices is essential to uncover tissue architecture and intercellular interactions. However, some of the current 3D ...

Cancer Res (2026) 86 (7_Supplement): 1470. Three-dimensional spatial transcriptomics (ST) is essential for characterizing tumor-microenvironment (TME) heterogeneity but profiling every serial section ...

In conventional pathology and physiology research, two-dimensional (2D) analysis—observing thinly sliced tissue sections—has been mainstream, making it difficult to comprehensively understand the ...

High transparency was achieved by optimizing the duration and procedures for delipidation and refractive index matching. (A) Tissue clearing of 11 organs from an adult mouse. (B) Whole-body tissue ...

Abstract: Spatial transcriptomics (ST) is an emerging technology that enables medical computer vision scientists to automatically interpret the molecular profiles underlying morphological features.

Neurodegenerative diseases affect more than 57 million people globally. The incidence of these diseases, from Alzheimer's to Parkinson's to ALS and beyond, is expected to double every 20 years. Though ...